Above results indicated that ACDB treatment strongly suppressed JJ012 xenograft tumor growth in vivo through regulation Bax, Bcl-2, GRP-94, and calpain I signaling (Supplementary Figure S2). This evidence concerns the gene BCL2 and neoplasm.